Bryan King, MD, MBA

Title(s)Professor, Psychiatry
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Biography 
    Collapse Education and Training
    University of California, IrvineBS1979Biological Sciences
    Medical College of WisconsinMD 1983Medicine
    UCLA Center for Health SciencesInternship1984Internal Medicine
    UCLA Neuropsychiatric InstituteResidency in Psychiatry1987Psychiatry
    UCLA Neuropsychiatric InstituteFellowship in Child and Adolescent Psychiatry1990Psychiatry
    George Washington UniversityMBA2014Business
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UC Irvine1979Phi Beta Kappa
    UC Irvine1979Magna Cum Laude
    UC Irvine1979Honors in Research
    NIMH1988Individual Research Service Award
    UCLA Neuropsychiatric Institute1988Gertrude Rogers Greenblatt Fellowship
    American Academy of Child and Adolescent Psychiatry1990George Tarjan Award
    UCLA Neuropsychiatric Institute Department of Nursing1997Outstanding Physician Award
    UCLA Neuropsychiatric Institute Department of Psychiatry1997Outstanding Mentor Award
    American Psychiatric Association2001Frank J. Menolascino Award
    Seattle Children's Hospital Family Advisory Council2007Annual Family Choice Award
    American Academy of Child and Adolescent Psychiatry2011Distinguished Fellow
    George Washington University School of Business2014Beta Gamma Sigma International Business Honor Society
    American Psychiatric Association2015Fellow

    Collapse Overview 
    Collapse Overview
    My research and clinical work has largely focused on psychiatric aspects of developmental disorders, and upon the pathogenesis and treatment of significant behavioral disturbance in autism and related disorders in particular. In recent years, this focus has been primarily directed on interventions in autism including both pharmacological and psychosocial treatments.

    Collapse Research 
    Collapse Research Activities and Funding
    2/4-RUPP Autism Network: Guanfacine for the Treatment of Hyperactivity in PDD
    NIH/NIMH R01MH086927Jul 1, 2010 - Sep 30, 2013
    Role: Principal Investigator
    UW Autism Center of Excellence
    NIH/NICHD P50HD055782Aug 6, 2007 - Jul 31, 2013
    Role: Principal Investigator
    NIH/NICHD R01HD033779Aug 1, 1996 - Sep 1, 1998
    Role: Principal Investigator
    NIH/NIMH K20MH000917Feb 1, 1991 - Jan 31, 1997
    Role: Principal Investigator
    NIH/NIMH F32MH009730Jan 25, 1989
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B). Contemp Clin Trials. 2020 Aug 07; 106103. Spanos M, Chandrasekhar T, Kim SJ, Hamer RM, King BH, McDougle CJ, Sanders KB, Gregory SG, Kolevzon A, Veenstra-VanderWeele J, Sikich L. PMID: 32777383.
      View in: PubMed   Mentions:    Fields:    
    2. Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder). Journal of the American Academy of Child & Adolescent Psychiatry. 2019 Nov 1. Matthew Siegel, Kelly McGuire, Jeremy Veenstra-VanderWeele, Katharine Stratigos, Bryan King, Christopher Bellonci, Munya Hayek, Helene Keable, Carol Rockhill, Oscar G. Bukstein, Heather J. Walter. .
      View in: Publisher Site   Mentions:
    3. Fluoxetine and Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorder. JAMA. 2019 10 22; 322(16):1557-1558. King BH. PMID: 31638657.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Overemphasis of the Autism Diagnostic Observation Schedule (ADOS) Evaluation Subverts a Clinician's Ability to Provide Access to Autism Services. J Am Acad Child Adolesc Psychiatry. 2019 12; 58(12):1222-1223. Gwynette MF, McGuire K, Fadus MC, Feder JD, Koth KA, King BH. PMID: 31356862.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Developmental social vulnerability as the intrinsic origin of psychopathology: A paradigm shift from disease entities to psychiatric derivatives within human diversity. Med Hypotheses. 2019 May; 126:95-108. Morioka H, Ijichi S, Ijichi N, Ijichi Y, King BH. PMID: 31010507.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder. Front Neurosci. 2019; 13:111. Ness SL, Bangerter A, Manyakov NV, Lewin D, Boice M, Skalkin A, Jagannatha S, Chatterjee M, Dawson G, Goodwin MS, Hendren R, Leventhal B, Shic F, Frazier JA, Janvier Y, King BH, Miller JS, Smith CJ, Tobe RH, Pandina G. PMID: 30872988.
      View in: PubMed   Mentions:
    7. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Compr Psychiatry. 2019 01; 88:57-64. Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L. PMID: 30504071.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology. 2018 07; 43(8):1772-1778. Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ. PMID: 29540864.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018 01; 32(1):3-29. Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, Loth E, McAlonan GM, McCracken JT, Parr JR, Povey C, Santosh P, Wallace S, Simonoff E, Murphy DG. PMID: 29237331.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    10. 21.0 Inpatient Treatment of Children With Autism and Intellectual Disability: Three Innovative Models. Journal of the American Academy of Child & Adolescent Psychiatry. 2017 Oct 1; 56(10):s30. Matthew Siegel, Bryan H. King. .
      View in: Publisher Site   Mentions:
    11. Disruption to control network function correlates with altered dynamic connectivity in the wider autism spectrum. Neuroimage Clin. 2017; 15:513-524. de Lacy N, Doherty D, King BH, Rachakonda S, Calhoun VD. PMID: 28652966.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    12. Association Between Maternal Use of SSRI Medications and Autism in Their Children. JAMA. 2017 04 18; 317(15):1568-1569. King BH. PMID: 28418468.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial. Neuropsychopharmacology. 2017 Jun; 42(7):1390-1398. Veenstra-VanderWeele J, Cook EH, King BH, Zarevics P, Cherubini M, Walton-Bowen K, Bear MF, Wang PP, Carpenter RL. PMID: 27748740.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    14. 4.6 Updates on Co-Occurring Conditions With Neurodevelopmental Disorders: Recognition and Treatment. Journal of the American Academy of Child & Adolescent Psychiatry. 2016 Oct 1; 55(10):s91-s92. Bryan H. King. .
      View in: Publisher Site   Mentions:
    15. Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound. Autism Res. 2017 Mar; 10(3):472-484. Webb SJ, Garrison MM, Bernier R, McClintic AM, King BH, Mourad PD. PMID: 27582229.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Psychiatric comorbidities in neurodevelopmental disorders. Curr Opin Neurol. 2016 Apr; 29(2):113-7. King BH. PMID: 26840045.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Assessing Risk of Autism Spectrum Disorder in Children After Antidepressant Use During Pregnancy. JAMA Pediatr. 2016 Feb; 170(2):111-2. King BH. PMID: 26660503.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials? Am J Bioeth. 2016; 16(4):72-4. Stein MA, King BH. PMID: 26982936.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Focus on Autism and Related Conditions. Focus (Am Psychiatr Publ). 2016 Jan; 14(1):3-8. Yu C, King BH. PMID: 31975786.
      View in: PubMed   Mentions:
    20. Children with autism spectrum disorder and social skills groups at school: a randomized trial comparing intervention approach and peer composition. J Child Psychol Psychiatry. 2016 Feb; 57(2):171-9. Kasari C, Dean M, Kretzmann M, Shih W, Orlich F, Whitney R, Landa R, Lord C, King B. PMID: 26391889.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. Am J Psychiatry. 2015 Dec; 172(12):1197-206. Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, Sanders R, Minjarez M, Cowen J, Mullett J, Page C, Ward D, Deng Y, Loo S, Dziura J, McDougle CJ. PMID: 26315981.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    22. The relationship between treatment attendance, adherence, and outcome in a caregiver-mediated intervention for low-resourced families of young children with autism spectrum disorder. Autism. 2016 08; 20(6):643-52. Carr T, Shih W, Lawton K, Lord C, King B, Kasari C. PMID: 26290524.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder. Autism. 2016 07; 20(5):528-37. Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L. PMID: 26187059.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    24. Promising forecast for autism spectrum disorders. JAMA. 2015 Apr 21; 313(15):1518-9. King BH. PMID: 25898047.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol. 2015 Jan; 52(1):25-35. de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A. PMID: 25532776.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    26. The peer relationships of girls with ASD at school: comparison to boys and girls with and without ASD. J Child Psychol Psychiatry. 2014 Nov; 55(11):1218-25. Dean M, Kasari C, Shih W, Frankel F, Whitney R, Landa R, Lord C, Orlich F, King B, Harwood R. PMID: 25039696.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    27. Caregiver-mediated intervention for low-resourced preschoolers with autism: an RCT. Pediatrics. 2014 Jul; 134(1):e72-9. Kasari C, Lawton K, Shih W, Barker TV, Landa R, Lord C, Orlich F, King B, Wetherby A, Senturk D. PMID: 24958585.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    28. Sunsetting DSM-IV's pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry. 2014 May; 53(5):494-6. King BH. PMID: 24745948.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. J Autism Dev Disord. 2014 May; 44(5):1128-43. Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, Scahill L. PMID: 24158679.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    30. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014 Apr; 44(4):958-64. Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH. PMID: 24272415.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    31. Update on diagnostic classification in autism. Curr Opin Psychiatry. 2014 Mar; 27(2):105-9. King BH, Navot N, Bernier R, Webb SJ. PMID: 24441420.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    32. Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents. J Child Adolesc Psychopharmacol. 2014 Mar; 24(2):83-9. Hilt RJ, Chaudhari M, Bell JF, Wolf C, Koprowicz K, King BH. PMID: 24506790.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014 Feb; 53(2):237-57. Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M. PMID: 24472258.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    34. Community child psychiatric medication experiences measured by an internet-based, prospective parent survey of retail pharmacy customers. Community Ment Health J. 2014 Feb; 50(2):172-8. Hilt R, Wolf C, Koprowicz K, Thomas E, Chandler M, Hao XL, Russell M, Le T, Hooks L, King B. PMID: 24323138.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder. Autism. 2015 Jan; 19(1):38-52. Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, Dawson G. PMID: 24259748.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    36. Mice exposed to diagnostic ultrasound in utero are less social and more active in social situations relative to controls. Autism Res. 2014 Jun; 7(3):295-304. McClintic AM, King BH, Webb SJ, Mourad PD. PMID: 24249575.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    37. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. JAMA Pediatr. 2013 Nov; 167(11):1045-52. King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. PMID: 24061784.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. J Am Acad Child Adolesc Psychiatry. 2014 Jan; 53(1):97-107.e1. Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B. PMID: 24342389.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    39. Training of child and adolescent psychiatry fellows in autism and intellectual disability. Autism. 2014 May; 18(4):471-5. Marrus N, Veenstra-Vanderweele J, Hellings JA, Stigler KA, Szymanski L, King BH, Carlisle LL, Cook EH, Pruett JR. PMID: 24113341.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord. 2013 Oct; 43(10):2341-52. Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, Dukes K, Vitiello B, Gadow K, Scahill L. PMID: 23400347.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    41. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013 Oct; 49(4):255-65. Krueger DA, Northrup H. PMID: 24053983.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansPHPublic Health
    42. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013 Oct; 49(4):243-54. Northrup H, Krueger DA. PMID: 24053982.
      View in: PubMed   Mentions: 200     Fields:    Translation:Humans
    43. Autism and developmental disorders: management of serious behavioral disturbance. Child Adolesc Psychiatr Clin N Am. 2014 Jan; 23(1):xiii-xv. Siegel M, King BH. PMID: 24231174.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Psychiatric assessment of severe presentations in autism spectrum disorders and intellectual disability. Child Adolesc Psychiatr Clin N Am. 2014 Jan; 23(1):1-14. King BH, de Lacy N, Siegel M. PMID: 24231163.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Outcome measures for clinical trials in fragile X syndrome. J Dev Behav Pediatr. 2013 Sep; 34(7):508-22. Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK. PMID: 24042082.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    46. DSM-5 and autism: kicking the tires and making the grade. J Am Acad Child Adolesc Psychiatry. 2013 May; 52(5):454-7. King BH, Veenstra-Vanderweele J, Lord C. PMID: 23622845.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Fear-potentiated startle response is unrelated to social or emotional functioning in adolescents with autism spectrum disorders. Autism Res. 2013 Oct; 6(5):320-31. Sterling L, Munson J, Estes A, Murias M, Webb SJ, King B, Dawson G. PMID: 23495221.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology. Annu Rev Clin Psychol. 2013; 9:555-87. de Lacy N, King BH. PMID: 23537488.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    49. Consensus paper: pathological role of the cerebellum in autism. Cerebellum. 2012 Sep; 11(3):777-807. Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, Estes AM, Goldowitz D, Heck DH, Kemper TL, King BH, Martin LA, Millen KJ, Mittleman G, Mosconi MW, Persico AM, Sweeney JA, Webb SJ, Welsh JP. PMID: 22370873.
      View in: PubMed   Mentions: 166     Fields:    Translation:HumansAnimalsCells
    50. Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders. J Am Acad Child Adolesc Psychiatry. 2012 Apr; 51(4):347-9. Swedo SE, Baird G, Cook EH, Happé FG, Harris JC, Kaufmann WE, King BH, Lord CE, Piven J, Rogers SJ, Spence SJ, Wetherby A, Wright HH. PMID: 22449639.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    51. Intellectual Disability (Mental Retardation). Clinical Child Psychiatry. 2012 Mar 30; 377-398. L. Lee Carlisle, Bryan H. King, Arthur Maerlender. .
      View in: Publisher Site   Mentions:
    52. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. J Autism Dev Disord. 2012 Mar; 42(3):432-40. Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A. PMID: 21667200.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Reduced transcript expression of genes affected by inherited and de novo CNVs in autism. Eur J Hum Genet. 2011 Jun; 19(6):727-31. Nord AS, Roeb W, Dickel DE, Walsh T, Kusenda M, O'Connor KL, Malhotra D, McCarthy SE, Stray SM, Taylor SM, Sebat J, King B, King MC, McClellan JM. PMID: 21448237.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    54. Is schizophrenia on the autism spectrum? Brain Res. 2011 Mar 22; 1380:34-41. King BH, Lord C. PMID: 21078305.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    55. The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents. Psychiatry Res. 2010 Aug 30; 179(1):69-74. Yen CF, King BH, Tang TC. PMID: 20472300.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    56. Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents. J Sleep Res. 2010 Mar; 19(1 Pt 1):12-8. Yen CF, King BH, Chang YP. PMID: 19682243.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    57. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009 Jun; 66(6):583-90. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. PMID: 19487623.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    58. Pharmacology and genetics of autism: implications for diagnosis and treatment. Per Med. 2008 Nov; 5(6):599-607. Brkanac Z, Raskind WH, King BH. PMID: 19727434.
      View in: PubMed   Mentions: 1     Fields:    
    59. Asperger's syndrome: diagnosis and treatment. Am J Psychiatry. 2008 Aug; 165(8):958-63. Toth K, King BH. PMID: 18676600.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Forces shaping the fastest evolving regions in the human genome. PLoS Genet. 2006 Oct 13; 2(10):e168. Pollard KS, Salama SR, King B, Kern AD, Dreszer T, Katzman S, Siepel A, Pedersen JS, Bejerano G, Baertsch R, Rosenbloom KR, Kent J, Haussler D. PMID: 17040131.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansAnimalsCells
    61. An update on pharmacologic treatments for autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2006 Jan; 15(1):161-75. King BH, Bostic JQ. PMID: 16321729.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    62. Mental Retardation. Clinical Child Psychiatry, Second Edition. 2005 Oct 7; 391-413. Bryan H. King, Matthew W. State, Arthur Maerlender. .
      View in: Publisher Site   Mentions:
    63. Autism spectrum disorders: emerging pharmacotherapy. Expert Opin Emerg Drugs. 2005 Aug; 10(3):521-36. Bostic JQ, King BH. PMID: 16083327.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis. Eur Child Adolesc Psychiatry. 2005 Jul; 14(4):183-90. de Vries P, Humphrey A, McCartney D, Prather P, Bolton P, Hunt A. PMID: 15981129.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    65. Outcome measures for clinical drug trials in autism. CNS Spectr. 2004 Jan; 9(1):36-47. Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. PMID: 14999174.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    66. Impact of recent findings on study design of future autism clinical trials. CNS Spectr. 2004 Jan; 9(1):49-56. Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R. PMID: 14999175.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    67. The Role of the Basal Ganglia in the Expression of Stereotyped, Self-Injurious Behaviors in Developmental Disorders. _categories":[{"id":"closed. 2004 Jan 1; 29:119-158. Howard C. Cromwell, Bryan H. King. .
      View in: Publisher Site   Mentions:
    68. International Review of Research in Mental Retardation. The role of the basal ganglia in the expression of stereotyped, self-injurious behaviors in developmental disorders. 2004; 29:120-158. Cromwell HC, King BH..
    69. Asperger syndrome: to be or not to be? Curr Opin Pediatr. 2003 Oct; 15(5):491-4. Foster B, King BH. PMID: 14508298.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Maladaptive behaviour in children and adolescents with Down's syndrome. J Intellect Disabil Res. 2002 Sep; 46(Pt 6):484-92. Dykens EM, Shah B, Sagun J, Beck T, King BH. PMID: 12354319.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    71. Psychopharmacology in mental retardation. Current Opinion in Psychiatry. 2002 Sep 1; 15(5):497-502. Bryan H. King. .
      View in: Publisher Site   Mentions:
    72. The quality of health care for adults with developmental disabilities. Public Health Rep. 2002 Mar-Apr; 117(2):174-84. Lewis MA, Lewis CE, Leake B, King BH, Lindemann R. PMID: 12357002.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    73. Treatment of pain in acutely burned children. J Burn Care Rehabil. 2002 Mar-Apr; 23(2):135-56. Stoddard FJ, Sheridan RL, Saxe GN, King BS, King BH, Chedekel DS, Schnitzer JJ, Martyn JA. PMID: 11882804.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    74. Pharmacotherapy in mental retardation. Current Opinion in Psychiatry. 2002; 15:497-502. King BH..
    75. Autism spectrum disorders: update of evaluation and treatment. Curr Psychiatry Rep. 2001 Oct; 3(5):361-5. Mikhail AG, King BH. PMID: 11559471.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Self-injurious behavior in mental retardation. Current Opinion in Psychiatry. 2001 Sep 1; 14(5):457-461. Ashraf G. Mikhail, Bryan H. King. .
      View in: Publisher Site   Mentions:
    77. Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities. J Am Acad Child Adolesc Psychiatry. 2001 Jun; 40(6):654-7. King BH, Wright DM, Snape M, Dourish CT. PMID: 11392342.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    78. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2001 Jun; 40(6):658-65. King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff S, Shah BG, Snape M, Shernoff EW, Williamson K, Cook EH. PMID: 11392343.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    79. Self-injurious behavior: gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev. 2001; 7(1):3-12. Schroeder SR, Oster-Granite ML, Berkson G, Bodfish JW, Breese GR, Cataldo MF, Cook EH, Crnic LS, DeLeon I, Fisher W, Harris JC, Horner RH, Iwata B, Jinnah HA, King BH, Lauder JM, Lewis MH, Newell K, Nyhan WL, Rojahn J, Sackett GP, Sandman C, Symons F, Tessel RE, Thompson T, Wong DF. PMID: 11241877.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    80. Self-injurious behaviour in mental retardation. Current Opinion in Psychiatry. 2001; 14:457-461. Mikhail AG, King BH..
    81. Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders. J Autism Dev Disord. 2000 Oct; 30(5):439-45. King BH. PMID: 11098881.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    82. Expert Consensus Guideline Series: Treatment of psychiatric and behavioral problems in mental retardation. Am J Ment Retard. 2000 May; 105(3):159-226. PMID: 10907489.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    83. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states. Exp Clin Psychopharmacol. 2000 Feb; 8(1):125-132. LaHoste GJ, Wigal T, King BH, Schuck SEB, Crinella FM, Swanson JM. PMID: 10743913.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    84. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation. Child Adolesc Psychiatr Clin N Am. 2000 Jan; 9(1):225-43, x-xi. Madrid AL, State MW, King BH. PMID: 10674198.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Mental Retardation and Comorbid Mental Disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1999 Dec; 38(12):1606-10. Szymanski L, King BH. PMID: 10596263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    86. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999 Dec; 38(12 Suppl):5S-31S. Szymanski L, King BH. PMID: 10624083.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Erratum: Association of an X-chromosome dodecamer insertional variant allele with mental retardation. Molecular Psychiatry. 1999 Mar 1; 4(2):197-197. R A Philibert, B H King, S Winfield, E H Cook, Y-H Lee, B Stubblefield, P Damschroder-Williams, C Dea, A Palotie, C Tengstrom, B M Martin, E I Ginns.
      View in: Publisher Site   Mentions:
    88. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients. J Am Acad Child Adolesc Psychiatry. 1999 Mar; 38(3):329-34. State MW, Dykens EM, Rosner B, Martin A, King BH. PMID: 10087695.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    89. Cortical damage enhances pemoline-induced self-injurious behavior in prepubertal rats. Pharmacol Biochem Behav. 1999 Feb; 62(2):223-7. Cromwell HC, Levine MS, King BH. PMID: 9972687.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    90. Selective serotonin re-uptake inhibitors in intellectual disability. Mental Retardation and Developmental Disabilities Research Reviews. 1999; 5:264-269. Racusin R, Kovner-Kline K, King BH..
    91. Selective serotonin reuptake inhibitors in intellectual disability. Developmental Disabilities Research Reviews. 1999 Jan 1; 5(4):264-269. Robert Racusin, Kathleen Kovner-Kline, Bryan H. King. .
      View in: Publisher Site   Mentions:
    92. Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. Am J Ment Retard. 1999 Jan; 104(1):67-77. Dykens EM, Cassidy SB, King BH. PMID: 9972835.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    93. Association of an X-chromosome dodecamer insertional variant allele with mental retardation. Mol Psychiatry. 1998 Jul; 3(4):303-9. Philibert RA, King BH, Winfield S, Cook EH, Lee YH, Stubblefield B, Damschroder-Williams P, Dea C, Palotie A, Tengstrom C, Martin BM, Ginns EI. PMID: 9702738.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    94. Molecular screening for proximal 15q abnormalities in a mentally retarded population. J Med Genet. 1998 Jul; 35(7):534-8. Jacobsen J, King BH, Leventhal BL, Christian SL, Ledbetter DH, Cook EH. PMID: 9678696.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    95. Paroxetine treatment of aggression and self-injury in persons with mental retardation. Am J Ment Retard. 1998 Mar; 102(5):427-37. Davanzo PA, Belin TR, Widawski MH, King BH. PMID: 9544340.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    96. Proton MR spectroscopy in four patients with Lesch-Nyhan Disease. American Journal of Neuroradiology. 1998; 19:672-674. Davanzo PA, Ke Y, King BH, Guze BH, McCracken J, Curran J, Thomas A.
    97. Self-injurious behaviour in mental retardation. Current Opinion in Psychiatry. 1998; 11:523-526. King BH, Lynn D.
    98. Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Dev Neurosci. 1998; 20(2-3):180-7. King BH, Cromwell HC, Lee HT, Behrstock SP, Schmanke T, Maidment NT. PMID: 9691192.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    99. Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol. 1998; 8(2):107-13. Krishnamoorthy J, King BH. PMID: 9730076.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    100. Developmental aspects of stereotyped movement disorder. Psychiatric Annals. 1998; 28:313-316. King BH, Krishnamurthy J.
    101. Mental retardation: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1997 Dec; 36(12):1656-63. King BH, State MW, Shah B, Davanzo P, Dykens E. PMID: 9401326.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    102. Mental retardation: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry. 1997 Dec; 36(12):1664-71. State MW, King BH, Dykens E. PMID: 9401327.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    103. Issues to consider in deaf and hard-of-hearing patients. The Committee on Disabilities of the Group for the Advancement of Psychiatry. Am Fam Physician. 1997 Nov 15; 56(8):2057-64, 2067-8. PMID: 9390099.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. Eating themselves to death: have "personal rights" gone too far in treating people with Prader-Willi syndrome? Ment Retard. 1997 Aug; 35(4):312-4. Dykens EM, Goff BJ, Hodapp RM, Davis L, Devanzo P, Moss F, Halliday J, Shah B, State M, King B. PMID: 9270240.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    105. Child and learning disability psychopharmacology. J Psychopharmacol. 1997; 11(4):291-4. PMID: 9443515.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    106. Pemoline alters dopamine modulation of synaptic responses of neostriatal neurons in vitro. Dev Neurosci. 1997; 19(6):497-504. Cromwell HC, King BH, Levine MS. PMID: 9445087.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    107. Pemoline produces ipsilateral turning behavior in unilateral 6-OHDA-lesioned rats. Prog Neuropsychopharmacol Biol Psychiatry. 1996 Apr; 20(3):503-14. Cromwell HC, Witte EA, Crawford CA, Ly HT, Maidment NT, King BH. PMID: 8771605.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    108. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. J Child Adolesc Psychopharmacol. 1996; 6(4):273-9. Davanzo PA, King BH. PMID: 9231320.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    109. Buspirone treatment of aggression and self-injury in autistic and non autistic persons with severe mental retardation. Developmental Brain Dysfunction. 1996; 9:22-31. King BH, Davanzo P.
    110. Dr. King and Colleagues Reply. American Journal of Psychiatry. 1995 Dec 1; 152(12):1837-a-1838. BRYAN H. KING, STEVEN R. FORNESS, JAMES T. MCCRACKEN. .
      View in: Publisher Site   Mentions:
    111. Pretreatment with MK-801 inhibits pemoline-induced self-biting behavior in prepubertal rats. Dev Neurosci. 1995; 17(1):47-52. King BH, Au D, Poland RE. PMID: 7621748.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    112. Psychiatric consultation in severe and profound mental retardation. Am J Psychiatry. 1994 Dec; 151(12):1802-8. King BH, DeAntonio C, McCracken JT, Forness SR, Ackerland V. PMID: 7977889.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    113. Simple versus Complex Conduct Disorders: Identification and Phenomenology. Behavioral Disorders. 1994 Aug 1; 19(4):306-312. Mary Margaret Kerr, Steven R. Forness, Kenneth A. Kavale, Bryan H. King, Connie Kasari. .
      View in: Publisher Site   Mentions:
    114. Simple versus complex conduct disorders: Identification and phenomenology. Behavioral Disorders. 1994; 19:306-312. Forness SR, Kavale K, King BH, Kasari C.
    115. Self-injury by people with mental retardation: a compulsive behavior hypothesis. Am J Ment Retard. 1993 Jul; 98(1):93-112. King BH. PMID: 8373567.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    116. Low-dose naltrexone inhibits pemoline-induced self-biting behavior in prepubertal rats. J Child Adolesc Psychopharmacol. 1993; 3(2):71-9. King BH, Au D, Poland RE. PMID: 19630639.
      View in: PubMed   Mentions:    Fields:    
    117. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. J Autism Dev Disord. 1992 Mar; 22(1):33-45. Yuwiler A, Shih JC, Chen CH, Ritvo ER, Hanna G, Ellison GW, King BH. PMID: 1375597.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    118. Comments on self-injurious behaviour. Am J Psychiatry. 1991 Nov; 148(11):1617-8. King BH, Poland RE. PMID: 1928505.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. Deficiency in the opioid hypotheses of self-injurious behavior. Am J Ment Retard. 1991 May; 95(6):692-4; discussion 694-6. King BH, McCracken JT, Poland RE. PMID: 1647799.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors. Blood Coagul Fibrinolysis. 1991 Feb; 2(1):17-24. Brazell C, McClue SJ, Preston GC, King B, Stahl SM. PMID: 1772986.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    121. Fluoxetine reduced self-injurious behavior in an adolescent with mental retardation. J Child Adolesc Psychopharmacol. 1991; 1(5):321-9. King BH. PMID: 19630681.
      View in: PubMed   Mentions:    Fields:    
    122. Hypothesis: involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis. Pharmacopsychiatry. 1990 Mar; 23(2):85-9. King BH. PMID: 2187212.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    123. Proposals for the mechanism of action of convulsive therapy: a synthesis. Biol Psychiatry. 1990 Jan 01; 27(1):76-94. King BH, Liston EH. PMID: 1967536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    124. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype. Neurosci Lett. 1989 Oct 23; 105(1-2):174-6. King BH, Brazell C, Dourish CT, Middlemiss DN. PMID: 2562060.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    125. Lies and liars: psychiatric aspects of prevarication. Am J Psychiatry. 1988 May; 145(5):554-62. Ford CV, King BH, Hollender MH. PMID: 3282449.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    126. Pseudologia fantastica. Acta Psychiatr Scand. 1988 Jan; 77(1):1-6. King BH, Ford CV. PMID: 3279719.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    127. Therapeutic sleep deprivation for depression in children. J Am Acad Child Adolesc Psychiatry. 1987 Nov; 26(6):928-31. King BH, Baxter LR, Stuber M, Fish B. PMID: 3429415.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    128. Pseudologia fantastica. Am J Psychiatry. 1987 Jul; 144(7):970-1. King BH, Ford CV. PMID: 3605419.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Pseudologia Fantastica. American Journal of Psychiatry. 1987 Jul 1; 144(7):970-a-970. BRYAN H. KING, CHARLES V. FORD. .
      View in: Publisher Site   Mentions:
    130. Developmental responses of the Drosophila melanogaster embryo to localized X irradiation. Radiat Res. 1982 Mar; 89(3):590-606. King BH, Bryant PJ. PMID: 6801720.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells